You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • THU0301 Safety following initiation of rituximab in granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA): interim analysis of the rituximab in anca-associated vasculitis registry (RAVER)

Article metrics

Article menu

Download PDFPDF

Poster Presentations
Vasculitis
THU0301 Safety following initiation of rituximab in granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA): interim analysis of the rituximab in anca-associated vasculitis registry (RAVER)
Free

 

Online download statistics by month:

Online download statistics by month: June 2017 to March 2024

AbstractFullPdf
Jun 20171401
Jul 20175201
Aug 20172804
Sep 20175203
Oct 20174405
Nov 20172602
Dec 20173000
Jan 20185403
Feb 20183802
Mar 20183400
Apr 20186208
May 20185204
Jun 20184000
Jul 20184000
Aug 20181200
Sep 20182205
Oct 20182000
Nov 20182604
Dec 20181001
Jan 20192402
Feb 20192201
Mar 2019804
Apr 2019003
May 2019402
Jun 2019802
Jul 2019603
Aug 20191002
Sep 2019201
Oct 2019201
Nov 2019402
Dec 20191603
Jan 2020001
Feb 2020402
Mar 2020001
Apr 2020200
May 2020401
Jun 20201002
Jul 2020400
Aug 2020604
Sep 20201403
Oct 20201400
Nov 2020602
Dec 2020601
Jan 2021202
Feb 2021001
Mar 2021002
Apr 2021205
May 2021402
Jul 2021403
Aug 2021005
Sep 2021002
Oct 20216016
Nov 20213012
Dec 2021804
Jan 2022400
Feb 2022800
Mar 20221005
Apr 2022500
May 20221406
Jun 20221603
Jul 20221000
Aug 20221203
Sep 2022406
Oct 2022502
Nov 2022901
Dec 2022601
Jan 2023201
Feb 2023400
Mar 2023902
Apr 2023301
May 20231702
Jun 2023201
Jul 20231003
Aug 2023203
Sep 2023001
Oct 2023200
Nov 2023400
Dec 20231201
Jan 2024802
Feb 2024301
Mar 2024403
Total10460188